A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)
Aminah Jatoi, Howard L. Ritter, Amylou Dueck, Phuong L. Nguyen, Daniel A. Nikcevich, Ronnie F. Luyun, Bassam I. Mattar, Charles L. Loprinzi
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)'. Together they form a unique fingerprint.